Citation
83 FR 58262
Multiple canonical documents share this first-page citation.
- National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings 83 FR 58262
- Prospective Grant of an Exclusive Patent License: Development and Commercialization of Chimeric Antigen Receptor (CAR) Therapies for the Treatment of FMS-Like Tyrosine Kinase 3 (FLT3) Expressing Cancers 83 FR 58262